Close Menu

NEW YORK (GenomeWeb) – Luminex has completed its roughly $90 million acquisition of molecular diagnostics firm Nanosphere, the firm announced today.

Its tender offer of $1.70 per share for all of the shares of Nanosphere expired as of midnight on June 29. According to Luminex, as of the expiration of the tender offer, a total of 45,252,609 shares were validly tendered and not withdrawn, representing a total of nearly 86 percent of Nanosphere's outstanding shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.